CLAMOXY-VET
Casper Pharma, LLC
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90600074 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Docket Number | TMK-2021-01 |
Timeline
| 2021-03-24 | Application Filed |
| 2021-06-29 | Location: NEW APPLICATION PROCESSING |
| 2021-06-29 | Status: Live/Pending |
| 2021-06-29 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Casper Pharma, LLC |
| Address | 2 Tower Center Boulevard, Suite 1101A East Brunswick NJ 08816 |
| Legal Entity Type | Limited Liability Company |
| Legal Entity State | NJ |
Documents
 Application | MULTI | 2021-03-24 |
 Drawing | JPEG | 2021-03-24 |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical and veterinary formulation for Skin and soft Tissue infections in Dogs and Cats |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-06-29 | 1 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2021-10-30 | 2 DOCK D:Assigned to Examiner |
| EXAMINERS AMENDMENT -WRITTEN | 2021-11-10 | 3 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2021-11-10 | 4 GNEA F:First Action |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2021-11-10 | 5 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2021-11-10 | 6 XAEC I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2021-12-07 | 7 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2021-12-07 | 8 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2021-12-07 | 9 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2021-12-07 | 10 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-01-05 | 11 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-01-19 | 12 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2022-02-08 | 13 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2022-02-08 | 14 NPUB E:E-Mail |
| EXTENSION OF TIME TO OPPOSE RECEIVED | 2022-03-04 | 15 ETOF T:TTAB Proceeding |
| OPPOSITION INSTITUTED NO. 999999 | 2022-08-08 | 16 OP.I T:TTAB Proceeding |
| OPPOSITION SUSTAINED NO. 999999 | 2022-11-08 | 17 OP.S T:TTAB Proceeding |
| OPPOSITION TERMINATED NO. 999999 | 2022-11-08 | 18 OP.T T:TTAB Proceeding |
| ABANDONMENT - AFTER INTER PARTES DECISION | 2022-11-08 | 19 ABN4 O:Outgoing Correspondence |
| ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION | 2022-11-08 | 20 MAB4 E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 